Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients

Infection

Volumn 40, Issue 3, 2012, Pages 271-278

  Mikulska, M ^a   Del Bono, V ^a   Bruzzi, P ^a   Raiola, A M ^a   Gualandi, F ^a   Van Lint, M T ^a   Bacigalupo, A ^a   Viscoli, C ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Bloodstream infection; Haematopoietic stem cell transplant; Mortality; Pseudomonas; Survival

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; FLUCONAZOLE; LEVOFLOXACIN; MEROPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ACINETOBACTER; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APLASTIC ANEMIA; ARTICLE; BLOODSTREAM INFECTION; BURKHOLDERIA CEPACIA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDEMIA; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CORYNEBACTERIUM; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUNGUS; GRAFT RECIPIENT; GRAFT REJECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYCOSIS; MYELOFIBROSIS; PREDICTION; PSEUDOMONAS AERUGINOSA; RALSTONIA PICKETTII; RELAPSE; RETROSPECTIVE STUDY; ROTHIA MUCILAGINOSA; SEPSIS; SEPTIC SHOCK; SERRATIA MARCESCENS; SPHINGOMONAS PAUCIMOBILIS; STAPHYLOCOCCUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS;

ADOLESCENT; ADULT; AGED; BACTEREMIA; BACTERIA; COHORT STUDIES; COINFECTION; FEMALE; FUNGEMIA; FUNGI; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84864280458     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0229-y     Document Type: Article

References (14)

1. Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small TN et al. Pre-and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005;7:11-7.
2. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis. 2001; 33:947-53.
3. Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007;40:63-70.
4. Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gramnegative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009;15:47-53.
5. Cappellano P, Viscoli C, Bruzzi P, Van Lint MT, Pereira CA, Bacigalupo A. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion. New Microbiol. 2007;30:89-99.
6. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36: 1103-10.
7. Scott BL, Park JY, Deeg HJ, Marr KA, Boeckh M, Chauncey TR et al. Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes. Biol Blood Marrow Transplant. 2008;14:799-806.
8. Johnson LE, D'Agata EM, Paterson DL, Clarke L, Qureshi ZA, Potoski BA et al. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis. 2009;11:227-34.
9. Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant. 2007;39:687-93.
10. Tumbarello M, Spanu T, Caira M, Trecarichi EM, Laurenti L, Montuori E et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2009;64:320-6.
11. Mikulska M, Del Bono V, Prinapori R, Boni L, Raiola AM, Gualandi F et al. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2010;12:505-12.
12. Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM et al. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant. 2006;38:813-9.
13. Steiner M, Villablanca J, Kersey J, Ramsay N, Haake R, Ferrieri P et al. Viridans streptococcal shock in bone marrow transplantation patients. Am J Hematol. 1993;42:354-8.
14. Bochud PY, Eggiman P, Calandra T, Van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis. 1994;18:25-31.